Twenty-four-hour treatment of MCF10.DCIS cells with 10 μM fluvastatin resulted in a 4.8-fold increased expression of ACAT2 transcripts as assayed by qPCR (Figure 1A, p < 0.0001). Here, ACAT2 is linked to ductal breast carcinoma in situ.